Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.46 AUD | +2.07% |
|
-2.77% | -14.88% |
May. 28 | Ord Minnett Starts Australian Clinical Labs at Buy, Price Target is AU$3.50 | MT |
May. 21 | Australian Clinical Expects Fiscal 2024 Earnings to Fall at Lower End of Forecast | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-14.88% | 335M | |
+19.84% | 84.94B | |
-25.24% | 74.07B | |
-1.34% | 26.15B | |
+4.56% | 18.03B | |
-9.29% | 17.38B | |
+4.52% | 16.01B | |
+78.16% | 13.7B | |
+77.84% | 13.13B | |
-26.14% | 12.74B |
- Stock Market
- Equities
- ACL Stock
- News Australian Clinical Labs Limited
- Australian Clinical Labs Posts H1 FY24 Revenue Down 6.4% to AU$337.3 Million; Underlying Diluted EPS of AU$0.0511